Published Date: 02 Mar 2023
Although further research is needed, these tools may improve clinical management.
Read Full NewsWomen living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according to a multiyear analysis involving more ...
In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...
Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets ...
1.
Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma
2.
The importance of breast cancer screening
3.
One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study
4.
Report provides global picture of wide inequalities in care for women's cancers
5.
Clinical trial could lead to new 'gold standard' test for prostate cancer detection
1.
Everything You Need to Know About Leiomyomas: A Comprehensive Guide
2.
Understanding Mantle Cell Lymphoma Prognosis.
3.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
4.
Unlocking the Potential of Leukemia Treatment: A New Hope for Patients
5.
Targeting Oncology: Expanding Combinatorial Strategies by 2025
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
3.
Navigating the Complexities of Ph Negative ALL - Part XII
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
5.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation